INVIVO THERAPEUTICS HOLDINGS (NVIV) Stock Analyst Earnings Estimates
NASDAQ:NVIV - Nasdaq - US46186M6057 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||||||
| EBITDA YoY % growth | -17.09M | -21.71M -27.03% | -23.51M -8.29% | -24.19M -2.89% | -12.68M 47.58% | -11.44M 9.78% | -9.05M 20.89% | -9.86M -8.95% | -10.59M -7.40% | |
| EBIT YoY % growth | -17.84M | -22.4M -25.56% | -24.06M -7.41% | -24.59M -2.20% | -12.77M 48.07% | -11.5M 9.95% | -9.1M 20.87% | -9.9M -8.79% | -10.65M -7.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -15,750.00 | N/A | -14,250.00 | -15,187.50 -6.58% | -8,812.50 41.98% | -882.00 89.99% | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2019 Q2Q % growth | -199.50 | -229.50 | 30.00 | 13.07% |
| Q3 2019 Q2Q % growth | -217.50 | -252.45 | 34.95 | 13.84% |
| Q2 2019 Q2Q % growth | -255.00 | -237.15 | -17.85 | -7.53% |
| Q1 2019 Q2Q % growth | -210.00 | -221.85 | 11.85 | 5.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |